altretamine has been researched along with Dysesthesia in 1 studies
Altretamine: A hexamethyl-2,4,6-triamine derivative of 1,3,5-triazine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Neijt, JP | 1 |
| ten Bokkel Huinink, WW | 1 |
| van der Burg, ME | 1 |
| van Oosterom, AT | 1 |
| Vriesendorp, R | 1 |
| Kooyman, CD | 1 |
| van Lindert, AC | 1 |
| Hamerlynck, JV | 1 |
| van Lent, M | 1 |
| van Houwelingen, JC | 1 |
1 trial available for altretamine and Dysesthesia
| Article | Year |
|---|---|
Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cy | 1984 |